Challenges and Advancements in Palliative Chemotherapy for Ampullary Adenocarcinoma.
作者信息
Kim Eui Joo
机构信息
Division of Gastroenterology, Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
出版信息
Gut Liver. 2024 Jul 15;18(4):560-561. doi: 10.5009/gnl240283.
Abstract
摘要
相似文献
1
Challenges and Advancements in Palliative Chemotherapy for Ampullary Adenocarcinoma.壶腹腺癌姑息化疗的挑战与进展
Gut Liver. 2024 Jul 15;18(4):560-561. doi: 10.5009/gnl240283.
2
Better outcome of XELOX chemotherapy in patients with advanced intestinal-type adenocarcinoma of the ampulla of Vater.XELOX 化疗在壶腹高级肠型腺癌患者中的更好结果。
Tohoku J Exp Med. 2013 Sep;231(1):21-8. doi: 10.1620/tjem.231.21.
3
[Present status and future prospect of the chemotherapy for ampullary cancer].壶腹癌化疗的现状与未来展望
Nihon Rinsho. 2015 Mar;73 Suppl 3:737-40.
4
Ampulla of vater adenocarcinoma in a BRCA2 germline mutation carrier.一位携带BRCA2种系突变的患者发生了壶腹腺癌。
J Gastrointest Cancer. 2014 Mar;45(1):87-90. doi: 10.1007/s12029-013-9479-5.
5
Outcomes of Palliative Chemotherapy for Ampulla of Vater Adenocarcinoma: A Multicenter Cohort Study.壶腹腺癌姑息化疗的结果：一项多中心队列研究。
Gut Liver. 2024 Jul 15;18(4):729-736. doi: 10.5009/gnl230164. Epub 2023 Dec 22.
6
Early occurrence of chylothorax related to thoracic irradiation and concomitant chemotherapy.与胸部放疗及同步化疗相关的乳糜胸早期发生
Clin Oncol (R Coll Radiol). 2005 Jun;17(4):291. doi: 10.1016/j.clon.2004.07.014.
7
Adenocarcinoma of the ampulla of Vater: what treatment options are available?壶腹腺癌：有哪些可用的治疗选择？
J Oncol Pharm Pract. 2015 Oct;21(5):364-9. doi: 10.1177/1078155214538086. Epub 2014 Jun 5.
8
The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater.一线铂类联合化疗治疗壶腹腺癌的疗效。
Med Oncol. 2010 Dec;27(4):1149-54. doi: 10.1007/s12032-009-9351-4. Epub 2009 Nov 7.
9
Adenocarcinoma of the ampulla of Vater: does the histopathologic type matter?壶腹腺癌：组织病理学类型重要吗？
Scand J Gastroenterol. 2011 Nov;46(11):1401-3. doi: 10.3109/00365521.2011.610006. Epub 2011 Aug 19.
10
Twenty-six cases of advanced ampullary adenocarcinoma treated with systemic chemotherapy.26 例晚期壶腹腺癌患者行全身化疗。
Jpn J Clin Oncol. 2014 Apr;44(4):324-30. doi: 10.1093/jjco/hyt237. Epub 2014 Jan 30.
本文引用的文献
1
Outcomes of Palliative Chemotherapy for Ampulla of Vater Adenocarcinoma: A Multicenter Cohort Study.壶腹腺癌姑息化疗的结果：一项多中心队列研究。
Gut Liver. 2024 Jul 15;18(4):729-736. doi: 10.5009/gnl230164. Epub 2023 Dec 22.
2
Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour-State of the Art and Perspectives.壶腹癌：组织学亚型、标志物和临床行为——现状与展望。
Curr Oncol. 2023 Jul 22;30(7):6996-7006. doi: 10.3390/curroncol30070507.
3
Treatment Approach to Adenocarcinoma of the Ampulla of Vater. Vater 壶腹腺癌的治疗方法。
Curr Treat Options Oncol. 2021 Sep 29;22(11):103. doi: 10.1007/s11864-021-00894-5.
4
Genome-Derived Classification Signature for Ampullary Adenocarcinoma to Improve Clinical Cancer Care.基于基因组的壶腹腺癌分类特征，以改善临床癌症护理。
Clin Cancer Res. 2021 Nov 1;27(21):5891-5899. doi: 10.1158/1078-0432.CCR-21-1906. Epub 2021 Aug 25.
5
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations.壶腹癌：测序分析确定TP53状态为一种新的独立预后因素以及ERBB、PI3K和WNT通路中具有潜在可靶向治疗价值的基因突变。
Ann Surg. 2018 Jan;267(1):149-156. doi: 10.1097/SLA.0000000000001999.
6
Better outcome of XELOX chemotherapy in patients with advanced intestinal-type adenocarcinoma of the ampulla of Vater.XELOX 化疗在壶腹高级肠型腺癌患者中的更好结果。
Tohoku J Exp Med. 2013 Sep;231(1):21-8. doi: 10.1620/tjem.231.21.
7
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.顺铂联合吉西他滨与吉西他滨治疗胆管癌。
N Engl J Med. 2010 Apr 8;362(14):1273-81. doi: 10.1056/NEJMoa0908721.
8
Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions.Vater壶腹癌及其前驱病变的组织病理学特征和微卫星不稳定性
Am J Surg Pathol. 2009 May;33(5):691-704. doi: 10.1097/PAS.0b013e3181983ef7.
9
Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.卡培他滨与奥沙利铂用于晚期小肠腺癌和壶腹腺癌的II期研究
J Clin Oncol. 2009 Jun 1;27(16):2598-603. doi: 10.1200/JCO.2008.19.7145. Epub 2009 Jan 21.
10
Survival after resection of ampullary carcinoma: a national population-based study.壶腹癌切除术后的生存率：一项基于全国人口的研究。
Ann Surg Oncol. 2008 Jul;15(7):1820-7. doi: 10.1245/s10434-008-9886-1. Epub 2008 Mar 28.
Zotero 插件